［1］ Li DJ,Li Q,He YT.Epidemiological trends of colorectal cancer［J］.Cancer Research on Prevention and Treatment,2015,42(3):305-310.［李道娟,李倩,贺宇彤.结直肠癌流行病学趋势［J］.肿瘤防治研究,2015,42(3):305-310.］
[2] Gao J,Li XL.Expression and clinical significance of Bmi-1 in colon cancer［J］.China Medicine and Pharmacy,2011,1(22):62-63.［高健,李相良.多梳基因-1在肠癌组织中的表达及其临床意义［J］.中国医药科学,2011,1(22):62-63.］
[3] Liu PW,Chen XY.Advances in studies on relationship between polycomb group gene Bmi-1 and gastric cancer ［J］.Chin J Gastroenterol,2011,16(3):178-180.［刘朋伟,陈晓宇.多梳基因Bmi-1与胃癌关系研究进展［J］.胃肠病学,2011,16(3):178-180.］
[4] Hourinaz B,Heeta B,Adrian MD,et al.Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation［J］.Disease Models & Mechanisms,2013,6(1):49-63.
[5] Yao D,Wang Y,Xue L,et al.Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma［J］.Hum Pathol,2013,44(5):844-851.
[6] Effendi K，Mori T，Komuta M，et al．Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression［J］．Cancer Sci，2010，101(3)：666-672.
[7]Haupt Y,Alexander WS,Barri G,et al.Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Emu-myc transgenic mice［J］.Cell,1991,65(5):753-763.
[8] Lu SQ,Jia ST,Luo Y.Recent advances in mutant p53 and novel personalized strategies for cancer therapy［J］.Hereditas,2011,33(6):539-548.［陆思千,贾舒婷,罗瑛.突变p53功能研究新进展与个性化的肿瘤治疗新策略［J］.遗传,2011,33(6):539-548.］
[9] Meng JL,Xu WH,Wang ZY,et al.Expression and significance of p53 and p21 WAFI /CIP1 in colon cancer ［J］.J Peking University:Health Sciences,2001,33(6):582.［孟基拉,徐文化,王智勇,等.大肠癌中p53和p21 WAFI /CIP1蛋白表达及其意义［J］.北京大学学报:医学版,2001,33(6):582.］
[10] Jiang L,Li J,Song L.Bmi-1,stem cells and cancer［J］.Acta Biochim Biophys Sin (Shanghai),2009,41(7):527-534.
[11] Jacobs JJ,Kieboom K,Marino S,et al.The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus［J］.Nature,1999,397(6715):164-168.
[12] Kim JH,Yoon SY,Kim CN,et al.The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins［J］.Cancer Lett,2004,203(2):217-224.
[13] Song LB,Zeng MS,Liao WT,et al.Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human asopharyngeal epithelial cells［J］.Cancer Res,2006,66(12):6225-6232.
[14] Wang YJ,Sun H，Liu GT，et al.Advances in the study of p53 in response to DNA damage ［J］.Acta Pharmaceutica Sinica,2011,46(12):1413-1419.［王娅杰,孙华,刘耕陶,等.p53在DNA损伤反应中的研究进展［J］.药学学报,2011,46(12):1413-1419.］
[15] Takeda T,Dong X,Take da H,et al.Successful immune therapy combined with hyperthermia therapy for cancer patients［J］.Gan To KagaKu Ryoho,2006,33(12):1739-1741.
[16] Kong FR,Wang LM,Dai SZ,et al.Expressions of B7-H4,CA125 and p53 in epithelial ovarian cancer and their clinical value［J］.J Shandong University(Health Sciences),2009,47(2):74-77.［孔凡荣,王黎明,戴淑真,等.B7-H4、CA125及p53在上皮性卵巢癌中的表达及意义［J］.山东大学学报（医学版）,2009,47(2):74-77.］
[17] Vonlanthen S,Heighway J,Altermatt HJ,et al.The Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression［J］.Br J Cancer，2001，84:1372-1376.
[18] Mindy AM,Roberta F,Keren IH.Bmi1 is required for tumorigenesis in a mouse model of intestinal cancer［J］.Oncogene,2014,33(28):3742-3747.